{"entity":{"type":"insider","cik":"0001688199","url":"/insider/0001688199","json_url":"/insider/0001688199.json","name":"Read Simon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":9,"first":"2019-06-19","last":"2026-08-19","span_basis":"filed_date"},"name_variants":[{"name":"Read Simon","source":"filing","n_filings":9,"first_seen":"2019-06-19","last_seen":"2026-08-19"}],"transactions":[{"id":9298734,"accession":"0001688199-26-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001688199-26-000006","line_url":"/filing/0001688199-26-000006#line-1","is_derivative":false,"issuer_cik":"0001690585","issuer_name":"Dianthus Therapeutics, Inc. /DE/","issuer_ticker":"DNTH","issuer_name_source":null,"issuer_url":"/issuer/0001690585","owner_cik":"0001688199","owner_name":"Read Simon","owner_display_name":"Read Simon","owner_url":"/insider/0001688199","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2778.0,"shares_display":"2,778","price_per_share":117.55,"price_display":"117.55","price_state":"stated","total_value":326553.9,"total_display":"326,553.90","total_whole":"326,554","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-19","scope":"insider"},{"id":9294804,"accession":"0001688199-26-000004","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001688199-26-000004","line_url":"/filing/0001688199-26-000004","is_derivative":false,"issuer_cik":"0001688199","issuer_name":"Dianthus Therapeutics, Inc. /DE/","issuer_ticker":"DNTH","issuer_name_source":null,"issuer_url":"/issuer/0001688199","owner_cik":"0001688199","owner_name":"Read Simon","owner_display_name":"Read Simon","owner_url":"/insider/0001688199","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2777.0,"shares_display":"2,777","price_per_share":109.55410514944184,"price_display":"109.55","price_state":"stated","total_value":304231.75,"total_display":"304,231.75","total_whole":"304,232","shares_owned_after":867.0,"shares_owned_after_display":"867","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-11","scope":"insider","n_lines":6},{"id":8310415,"accession":"0001104659-19-073911","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-073911","line_url":"/filing/0001104659-19-073911#line-2","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688199","owner_name":"Read Simon","owner_display_name":"Read Simon","owner_url":"/insider/0001688199","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":47.0821,"price_display":"47.08","price_state":"stated","total_value":470821.0,"total_display":"470,821.00","total_whole":"470,821","shares_owned_after":6234.0,"shares_owned_after_display":"6,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-17","filed_date":"2019-12-18","scope":"insider"},{"id":8030552,"accession":"0001104659-19-065128","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-065128","line_url":"/filing/0001104659-19-065128#line-2","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688199","owner_name":"Read Simon","owner_display_name":"Read Simon","owner_url":"/insider/0001688199","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":46.6808,"price_display":"46.68","price_state":"stated","total_value":466808.0,"total_display":"466,808.00","total_whole":"466,808","shares_owned_after":6234.0,"shares_owned_after_display":"6,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-18","scope":"insider"},{"id":8476269,"accession":"0001104659-19-054728","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-054728","line_url":"/filing/0001104659-19-054728#line-2","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688199","owner_name":"Read Simon","owner_display_name":"Read Simon","owner_url":"/insider/0001688199","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":46.8726,"price_display":"46.87","price_state":"stated","total_value":468726.0,"total_display":"468,726.00","total_whole":"468,726","shares_owned_after":6234.0,"shares_owned_after_display":"6,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-16","filed_date":"2019-10-17","scope":"insider"},{"id":7969965,"accession":"0001104659-19-050299","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-050299","line_url":"/filing/0001104659-19-050299#line-2","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688199","owner_name":"Read Simon","owner_display_name":"Read Simon","owner_url":"/insider/0001688199","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.405,"price_display":"25.40","price_state":"stated","total_value":254050.0,"total_display":"254,050.00","total_whole":"254,050","shares_owned_after":6234.0,"shares_owned_after_display":"6,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-12","filed_date":"2019-09-16","scope":"insider"},{"id":7810520,"accession":"0001104659-19-047565","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-047565","line_url":"/filing/0001104659-19-047565#line-2","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688199","owner_name":"Read Simon","owner_display_name":"Read Simon","owner_url":"/insider/0001688199","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":27.7703,"price_display":"27.77","price_state":"stated","total_value":277703.0,"total_display":"277,703.00","total_whole":"277,703","shares_owned_after":6234.0,"shares_owned_after_display":"6,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-23","filed_date":"2019-08-27","scope":"insider"},{"id":8054048,"accession":"0001104659-19-041021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-19-041021","line_url":"/filing/0001104659-19-041021#line-2","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688199","owner_name":"Read Simon","owner_display_name":"Read Simon","owner_url":"/insider/0001688199","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":32.9479,"price_display":"32.95","price_state":"stated","total_value":329479.0,"total_display":"329,479.00","total_whole":"329,479","shares_owned_after":6234.0,"shares_owned_after_display":"6,234","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-17","filed_date":"2019-07-18","scope":"insider"},{"id":8441317,"accession":"0001104659-19-036492","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-19-036492","line_url":"/filing/0001104659-19-036492","is_derivative":false,"issuer_cik":"0001481512","issuer_name":"Ra Pharmaceuticals, Inc.","issuer_ticker":"RARX","issuer_name_source":null,"issuer_url":"/issuer/0001481512","owner_cik":"0001688199","owner_name":"Read Simon","owner_display_name":"Read Simon","owner_url":"/insider/0001688199","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"COMMON STOCK","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":22.24674442,"price_display":"22.25","price_state":"stated","total_value":222467.4442,"total_display":"222,467.44","total_whole":"222,467","shares_owned_after":6648.0,"shares_owned_after_display":"6,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-18","filed_date":"2019-06-19","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001690585","name":"Dianthus Therapeutics, Inc. /DE/","url":"/issuer/0001690585","role":"Director","n_filings":2,"first_seen":"2026-08-11","last_seen":"2026-08-19"},{"type":"issuer","type_label":"ISSUER","cik":"0001481512","name":"Ra Pharmaceuticals, Inc.","url":"/issuer/0001481512","role":"Officer (Chief Scientific Officer)","n_filings":7,"first_seen":"2019-06-19","last_seen":"2019-12-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001688199","retrieved_at":"2026-08-24T10:02:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}